ARIAD Pharmaceuticals, Inc.
Edit Page
Report
Scan day: 12 February 2014 UTC
12
Virus safety - good
Description: Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA)
ARIAD Pharmaceuticals, Inc: Home Our Vision, Mission & Values Our Vision, Mission & Values A disciplined, highly targeted approach to discovering new cancer medicines Rigorous, definitive clinical trials based on deep biology and chemistry expertise
Size: 265 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | ARIAD Pharmaceuticals, Inc: Home |
| Keywords: | cancer medication,reimbursement support,ariad,new medicine,cancer patients,cancer research,clinical trials,medicines |
| Description: | Our mission is to discover, develop and commercialize small-molecule medicines to treat cancer in patients with the greatest unmet medical need—those with aggressive cancers where current therapies are inadequate. We are committed to the highest standards of integrity and stewardship in service to patients, the medical community, employees and shareholders. |
| IP-address: | 173.203.62.111 |
WHOIS Info
| NS | Name Server: AUTH1.DNS.COGENTCO.COM Name Server: AUTH2.DNS.COGENTCO.COM Name Server: AUTH4.DNS.COGENTCO.COM |
| WHOIS | Status: clientDeleteProhibited Status: clientTransferProhibited Status: clientUpdateProhibited |
| Date | Creation Date: 08-oct-1992 Expiration Date: 07-oct-2018 |